Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients

References

• Kannel W B, Dawber T R, McGee D L. Perspectives on systolic hypertension. The Framingham Study. Circulation 1980; 61: 1179–82
   PubMed Web of Science ®Google Scholar
• Van Noord P AH, Seidell J C, den Tonkelaar I, Baanders-van Halewijn E A, Ouwehand I J. The relationship between fat distribution and some chronic diseases in 11,825 women participating in the DOM-project. Int J Epiderm 1990; 19: 3
   Google Scholar
• Stamler J, Wentworth D, Neaton J D. MRFIT Research Group. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? The Multiple Risk Factor Intervention Trial. J Am Med Ass 1986; 256: 2823–8
   PubMed Web of Science ®Google Scholar
• Kannel W B. Lipids, diabetes and coronary heart disease: Insight from the Framingham Study. Am Heart J 1985; 110: 1100–7
   PubMed Web of Science ®Google Scholar
• Kannel W B, Castelli W P, Gordon T, McNamara P M. Serum cholesterol lipoprotein and the risk of coronary heart disease. The Framingham Study. Ann Intern Med 1971; 74: 1–12
   PubMed Web of Science ®Google Scholar
• Castelli W P. The epidemiology of coronary heart disease: the Framingham Study. Am J Med 1984; 76: 4–12
   PubMed Web of Science ®Google Scholar
• Kannel W B. High density lipoproteins: Epidemiologic profile and risks of coronary artery disease. Am J Cardiol 1983; 52: 9B–12B
   PubMed Web of Science ®Google Scholar
• Jacobs D R, Mevane J C, Bangdiwala S I, Criqui M H, Tyroler H A. High density lipoprotein cholesterol as a predictor of cardiovascular disease mortality in men and women: the follow-up of the Lipid Research Clinics prevalence study. Am J Epidemiol 1990; 131: 32–47
   PubMed Web of Science ®Google Scholar
• Castelli W P. The triglyceride issue: a view from Framingham. Am Heart J 1986; 112: 432–7
   PubMed Web of Science ®Google Scholar
• Carlson C A, Bottiger L E. Ischaemic heart disease in relation to factual values of plasma triglycerides and cholesterol. Lancet 1972; i: 865–8
   Google Scholar
• Aberg H, Lithell H, Selinns I, Hedstrand H. Serum triglycerides are a risk factor for myocardial infarction but not for angina pectoris. Results from a 10-year follow-up of Uppsala primary preventive study. Atherosclerosis 1985; 54: 89–97
   PubMed Web of Science ®Google Scholar
• Hulley S H, Rosenman R H, Bawol R D, Brand R J. Epidemiology as a guide to clinical decisions. N Engl J Med 1980; 25: 1383–9
   Google Scholar
• Austin M A. Plasma triglyceride as a risk factor for coronary heart disease: the epidemiologic evidence and beyond. Am J Epidemiol 1989; 129: 249–59
   PubMed Web of Science ®Google Scholar
• Austin M A. Review: plasma triglyceride and coronary heartdisease. ArteriosclerThromb 1991; 11: 2–14
   PubMed Web of Science ®Google Scholar
• Schaefer E J, Levy R I, Anderson D W, Danner R N, Brewer H B, Blackwelder W C. Plasma triglycerides in regulation of HDL-cholesterol levels. Lancet 1978; ii: 391–3
   Google Scholar
• Davis C E, Gordon D, LaRosa J, Wood P D, Hal-Perin M. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations: the Lipid Research Clinics Program Prevalence Study. Circulation 1980; 62(suppl IV)IV-24–30
   Google Scholar
• Meade T W, North W RS, Chakrabarti R, Stirling Y, Haines A P, Thompson S G, Brozovic M. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980; i: 1050–4
   Google Scholar
• Meade T W, Mellows S, Brozovic M, Miller G J, Chakrabarti R R, North W RS, Haines A P, Stirling Y, Imeson J D, Thompson S G. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533–7
   Google Scholar
• Cooper J, Douglas A S. Fibrinogen level as a predictor of mortality in survivors of mycardial infarction. Fibrinolysis 1991; 5: 105–8
   Google Scholar
• Broadhurst P, Kelleher C, Hughes L, Imeson J D, Raftery E B. Fibrinogen, factor VII clotting activity and coronary artery disease severity. Atherosclerosis 1990; 85: 169–73
   PubMed Web of Science ®Google Scholar
• Tofler G M, Brezinski D, Schafer A I. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316: 1514–8
   PubMed Web of Science ®Google Scholar
• Trip M D, Manger Cats V, van Capelle F JL, Vreeken J. Platelet hyper-reactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549–54
   PubMed Web of Science ®Google Scholar
• Dalaker K, Hjermann I, Prydz H. A novel form of factor VII in plasma from men at risk for cardiovascular disease. Br J Haematol 1985; 61: 315–22
   Google Scholar
• Constantino M, Merskey C, Kudzma D J, Zucker M B. Increased activity of vitamin K-dependent clotting factors in human hyperlipoproteinaemia association with cholesterol and triglycerides levels. Thromb Haemost 1977; 38: 465–75
   Google Scholar
• Elkeles R S, Chakrabarti R, Vickers M, Stirling Y, Meade T W. Effect of treatment of hyperlipidaemia on haemostatic variables. Br Med J 1980; 281: 973–4
   PubMed Web of Science ®Google Scholar
• Simpson H CR, Mann J I, Meade T W, Chakrabarti R, Stirling Y, Woolf L. Hypertriglyceridaemia and hypercoagulability. Lancet 1983; i: 786–90
   Google Scholar
• Nordøy A, Illingworth D R, Connor W E, Goodnight S. Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipi-daemia. Haemostasis 1990; 20: 65–72
   Google Scholar
• Carvalho de Sousa J, Bruckert E, Giral P, Sonia C, Chapman J, Truffert J, Dairou F, De Gennes J C, Caen J P. Coagulation factor VII and plasma triglycerides: decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostasis 1989; 19: 125–3
   Google Scholar
• Nordøy A, Rodset J M. Platelet function and platelet phospholipids in patients with hyperbetalipo-proteinaemia. Acta Medica Scandinavica 1971; 189: 385–9
   Google Scholar
• Zahavi J, Betteridge J D, Jones N AG, Galton D J, Kakkar W. Enhanced in vivo platelet release reaction and malondialdehyde formation in patients with hyperlipidaemia. Am J Med 1981; 70: 59–64
   PubMed Web of Science ®Google Scholar
• Patrassi G M, Fallo F, Santarossa A, Sartori M T, Casonato A, Girolami A. Clotting changes in borderline hypertension. J Hum Hyperten 1987; i: 101–3
   Google Scholar
• Boneu B, Durand D, Counillon F, Charlet J P, Bierme R, Sue J M. Increased level of factor VII complex in severe arterial hypertension. Haemostasis 1978; 7: 332–8
   Google Scholar
• Patrassi G M, Fallo F, Martinelli S, Mantero F, Boeri G, Girolami A. The contact phase of blood coagulation and renin activation in essential hypertension before and after captopril. Eur Heart J 1984; 5: 561–7
   PubMedGoogle Scholar
• Yamanishi J, Sano H, Siato K, Furuta Y, Fukuzaki H. Plasma concentrations of platelet-specific proteins in different stages of hypertension: interaction between platelet aggregation, blood lipids and age. Thromb Haemost 1985; 54: 539–43
   PubMed Web of Science ®Google Scholar
• van Wersch J WJ, Rompelberg-Lahaye J, Luster-Mans FATh. Plasma concentration of coagulation and fibrinolysis factors and the level of platelet function in hypertension. Eur J Clin Chem Clin Biochem 1991; 29: 375–9
   PubMedGoogle Scholar
• Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H. Lipoprotein(a) and coronary heart disease: a prospective case control study in a general population sample of middle aged men. Br Med J 1990; 301: 1248–51
   PubMed Web of Science ®Google Scholar
• Roberts W C. Atherosclerotic risk factors: are there ten or is there only one? Am J Cardiol 1989; 64: 552–4
   Google Scholar
• Castelli W P, Anderson K. A population at risk: prevalence of high cholesterol levels if hypertensive patients in the Framingham study. Am J Med 1986; 80(suppl 2a)23–32
   PubMed Web of Science ®Google Scholar
• Leren P, Foss O P, Helgeland A, Hjermann I, Holme I, Lund-Larsen P G. Effect of propanolol and prazosin on blood lipids. The Oslo Study Lancet 1982; ii: 4–6
   Google Scholar
• Shen D C, Shieh S H, Fuh M T, Wu D A, Chen Y Dc, Reaven G M. Resistance to insulin stimulated glucose uptake in patients with hypertension. J Clin Endocrinol Metab 1988; 66: 580–3
   PubMed Web of Science ®Google Scholar
• Reaven G M. Banting lecture Role of insulin resistance in human disease Diabetes 1988; 37: 1595–1607
   Google Scholar
• Ferranini E, Buzzigoli G, Bonadonna R, Giorico M A, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S. Insulin resistance in essential hypertension. N Eng J Med 1987; 317: 350–7
   PubMed Web of Science ®Google Scholar
• Salomaa A, Strandberg T E, Vanharen H, Naukar-Innen V, Sarna S, Miettinen T A. Glucose tolerance and blood pressure: long term follow up in middle aged men. Br Med J 1991; 302: 493–6
   PubMed Web of Science ®Google Scholar
• Landin K, Tengborn L, Smith U. Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors. J Intern Med 1991; 229: 181–7
   PubMed Web of Science ®Google Scholar
• Vane J R, Anggard E E, Botting R M. Review article: regulatory function of the vascular endothelium. N Engl J Med 1990; 323: 27–36
   PubMed Web of Science ®Google Scholar
• Panza J A, Quyyumi A A, Brush J E, Epstein S E. Abnormal enothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 232: 22–7
   Google Scholar
• Haudenschild C C, Prescott M F, Chobanian A V. Effects of hypertension and its reversal on aortic intima lesions of the rat. Hypertension 1979; 2: 33–44
   Web of Science ®Google Scholar
• Limas C, Westrum B, Iwai J, Limas C J. Aortic morphology in salt-dependent genetic hypertension. Am J Pathol 1982; 107: 378–94
   Google Scholar
• Chobanian A V. The influence of hypertension and other hemodynamic factors in atherogenesis. Prog Cardiovasc Dis 1983; 26: 177–96
   PubMed Web of Science ®Google Scholar
• Chobanian A V, Lichtenstein A H, Nilakhe V, Haudenschild C C, Drago R, Nickerson C. Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension 1989; 14: 203–9
   PubMed Web of Science ®Google Scholar
• Miller G J, Walter S J, Stirling Y, Thompson S G, Esnout M P, Meade T W. Assay of factor VII activity by two techniques: evidence for increased conversion of VII to α VII in hyperlipidaemia, with possible implications for ischaemic heart disease. Br J Haematol 1985; 59: 249–58
   PubMed Web of Science ®Google Scholar
• Skartlien A H, Lyberg-Beckmann S, Holme I, Hjermann I, Prydz H. Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma. Arteriosclerosis 1989; 9: 798–801
   PubMedGoogle Scholar
• Smith E B, Staples E M, Dietz H S, Smith R H. Role of endothelium in sequestration of lipoprotein and fibrinogen in aortic lesions, thrombi and graft pseudo-intimas. Lancet 1979; ii: 812–6
   Google Scholar
• Smith E B, Staples E M. Haemostatic factors in human aortic intima. Lancet 1981; i: 117–9
   Google Scholar
• Niendorf A, Rath M, Wolf K, Peters S, Arps H, Beisiegel H, Dietel M. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries. Virchows Archiv A 1990; 417: 105–11
   Google Scholar